Dan J. Schneider

Assistant professor
Hematology, Oncology and Transplantation
HealthPartners Research Foundation
United States of America

Professor Haematology
Biography

Dan J. Schneider is a Investigator, Metro-Minnesota Community Oncology Research Consortium and Assistant professor, Department of Hematology, Oncology and Transplantation, University of Minnesota.Schneider had completed his MD, Southern Illinois University; fellowship in hematology and oncology, Loyola University, Chicago.

Research Intrest

Dr. Schneider has been recognized for his leadership in the Minnesota Cooperative Group Outreach Program. While he is interested in all cancer treatment, he particularly enjoys approaching therapy through clinical trials, a mechanism to further improve our knowledge and success rates.

List of Publications
Dudek AZ, Larson T, McCleod MJ, Schneider DJ, Dowell JE (2008)Phase 1/2 dose escalating study of twice-monthly pemetrexed and gemcitabine in patients with advanced cancer and non-small cell lung cancer.J Thorac Oncol. 3:394-399.
McWilliams RR, Foster NR, Mahoney MR, Smyrk TC, Murray JA (2017) North Central Cancer Treatment Group N0543 (Alliance): A phase 2 trial of pharmacogenetic-based dosing of irinotecan, oxaliplatin, and capecitabine as first-line therapy for patients with advanced small bowel adenocarcinoma.Cancer.